NCT03484117

Brief Summary

A randomized trial to test the feasibility and acceptability of an intervention to improve retention in HIV primary care in HIV-infected Hispanic immigrants compared to a "treatment as usual" condition. We will measure feasibility, acceptability, study retention, and effect sizes of outcomes in order to inform a larger trial. The intervention design is based on qualitative research with HIV-infected Hispanic immigrants and their HIV providers. The intervention will be led by a Spanish-speaking community health worker trained in HIV health promotion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 26, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 30, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

December 23, 2022

Completed
Last Updated

December 23, 2022

Status Verified

December 1, 2022

Enrollment Period

1.9 years

First QC Date

March 7, 2018

Results QC Date

July 27, 2022

Last Update Submit

December 1, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Retention in Care - Yes Responses

    A dichotomized outcome (yes/no) with yes defined as at least one visit to HIV clinic at both time periods (week 1-16 and week 17-32), and no defined as no HIV visit from at least one time period. Responses determined by review of the medical record for evidence of attended HIV clinic visits.

    32 weeks

Secondary Outcomes (4)

  • Number of Participants With HIV Viral Load Suppression up to Week-24

    From baseline to week-24

  • Change in CD4 T-cell Count Over 24 Weeks

    From baseline to week-24

  • Number of Participants With HIV Viral Load Suppression up to 48 Weeks.

    Baseline to week-48

  • Change in CD4 T-cell Count Over 48 Weeks.

    Baseline to week-48

Study Arms (2)

Treatment as Usual

NO INTERVENTION

Participants in this arm will receive bilingual written materials on healthy living with HIV at the baseline visit. At baseline and exit, all participants will be assessed using instruments to measure demographics and self-perceived barriers to care for Hispanic immigrants.

Community Health Worker

EXPERIMENTAL

Participants in the intervention arm will receive 5 one-on-one sessions over 24 weeks with a Spanish-speaking CHW. At baseline and exit, all participants will be assessed using instruments to measure demographics and self-perceived barriers to care for Hispanic immigrants

Behavioral: Community Health Worker

Interventions

Participants will receive 5 one-on-one sessions with a CHW over 24 weeks.

Community Health Worker

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older and able to communicate in Spanish or English
  • Born in Puerto Rico or Spanish-speaking Latin American country
  • HIV-infected or HIV-positive
  • New HIV diagnosis or unable to regularly attend HIV primary care appointments

You may not qualify if:

  • Unable to provide verbal consent due to unstable medical or psychiatric condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

Community Health Workers

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Allied Health PersonnelHealth PersonnelHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Dr. Julie Levison, PI
Organization
Massachusetts General Hospital

Study Officials

  • Julie H Levison, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MPhil, MPH, Assistant Professor of Medicine at Harvard Medical School

Study Record Dates

First Submitted

March 7, 2018

First Posted

March 30, 2018

Study Start

May 26, 2017

Primary Completion

May 1, 2019

Study Completion

May 1, 2019

Last Updated

December 23, 2022

Results First Posted

December 23, 2022

Record last verified: 2022-12

Locations